Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Conference Sponsor
1
2018 - 01 - 22
点击次数:
Shanghai Universal Biotech Company (www.univ-bio.com) was founded in the end of 2004. We always focus on antibodies and related products during the past 13 years. We are Antibody Expert among our clients. Now we have 19 branch offices all over China and over 300 staffs. We offered a wide product portfolio such as Antibodies, Recombinant Proteins, ELISA kits, Flow cytometry Reagents, IHC Reagents, Biochemicals, Molecular Biological Reagents, Cell lines and Cell Culture Products, LabEx (Antibody related technology CRO service) and Scientific Instruments. We offer service to over 50K end users. Univerisities / Institutes / Hospitals / Pharmaceuticals / Biotech Industrials are our clients. Currently we cooperate with these following manufacturers: BD (BD Bioscience), CST (Cell Signaling Technology), Merck-Sigma, GE-Healthcare, Bio-techne (R&D systems), Miltenyi, Cisbio, Qiagen, Carna, MSD (Meso Scale Diagnostics) and so on. We focus, we are professional. You can place orders over 1 Milliion of products on our website (www.univ-bio.com) directly.
2
2018 - 01 - 22
点击次数:
Proswell
3
2018 - 01 - 22
点击次数:
Shanghai LIDE Biotechnology Co., Ltd. ("Shanghai LIDE"), is committed to translational medicine and precision medical research of cancer, provide drug treatment guides to physicians, and proposing personalized treatment plans. The key technology platform is three functional diagnostics recommended by NCI: MINI PDX/PDX (Patient Derived Xenograft); CR (Conditional Reprogramming Cells) and Organoid.   OncoVee® MINI PDX is company patented technology, a 7 days in vitro drug sensitivity test that can be used at pre-clinical for drug screening as well as translational use at clinic for personalized medicine.The company owns AAALAC accredited SPF level animal centers and world-class equipment. Shanghai LIDE has two wholly-owned subsidiaries, "Xi'an LIDE Biotechnology Co., Ltd." and "Shanghai LIWEN Diagnostics" (hereinafter referred to as "Shanghai LIWEN") both with qualification of clinical testing laboratory. Shanghai LIDE was listed on the "New OTC Market" in August 2016 (stock code: 838848),